Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004650264 | SCV005145871 | uncertain significance | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | The c.3305A>G (p.N1102S) alteration is located in exon 16 (coding exon 16) of the NPC1L1 gene. This alteration results from a A to G substitution at nucleotide position 3305, causing the asparagine (N) at amino acid position 1102 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |